Investor Presentation Q1-Q3 2020
105
Investor presentation
First nine months of 2020
Insulin market size and volume market share in
North America Operations
Total
Insulin market share and market size (DKK billion)
Long-
acting
39%
43%
Fast-
51%
77
acting
58%
Premix
10
106
29%
Human
16
Novo Nordisk
Competitors
Note: Insulin market numbers do not reflect rebates. See slide 97.
Novo Nordisk®
Market
growth
A Market
share
Insulin volume: market share
60%
10%
210
1%
+0.1%
8%
50%
40%
6%
3%
-0.2%
40%
4%
30%
2%
-0.8%
+1.3%
0%
20%
0%
10%
-9%
-0.8%
0%
Aug
2017
-2%
-4%
Aug
2020
2%
-0.9%
Source: IQVIA, Aug 2020, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk
-NN market share
-Market growth (right axis)
NN growth (right axis)View entire presentation